Relationship of cell proliferation (Ki-67) to 99mTc-(V) DMSA uptake in breast cancer

被引:32
作者
Papantoniou, VJ
Souvatzoglou, MA
Valotassiou, VJ
Louvrou, AN
Ambela, C
Koutsikos, J
Lazaris, D
Christodoulidou, JK
Sotiropoulou, MG
Melissinou, MJ
Perperoglou, A
Tsiouris, S
Zerva, CJ
机构
[1] Alexandra Univ Hosp, Dept Nucl Med, Athens 11528, Greece
[2] Alexandra Univ Hosp, Dept Obstet & Gynaecol, Athens, Greece
[3] Alexandra Univ Hosp, Dept Radiol, Athens, Greece
[4] Alexandra Univ Hosp, Dept Pathol, Athens, Greece
[5] Metropolitan Hosp, Dept Internal Med, Athens, Greece
[6] Iaso Hosp, Dept Res & Stat, Athens, Greece
关键词
breast cancer; Ki-67; Tc-99m-MIBI; Tc-99m-(V) DMSA; scintimammography;
D O I
10.1186/bcr751
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction The aim of the present study was to identify the relationships between the uptake of radiotracers - namely pentavalent dimercaptosuccinic acid [( V) DMSA] and sestamibi ( MIBI) - and the following parameters in primary breast cancer: steroid receptor concentrations (i.e. estrogen receptor [ER] and progesterone receptor [ PR]), Ki-67 expression, tumor size, tumor grade, age, and levels of expression of p53 and c-erbB-2. In addition, by multivariate regression analysis, we further isolated those factors with independent associations with ( V) DMSA and/or MIBI uptake in primary breast cancer. Methods Thirty-four patients with histologically confirmed breast carcinoma underwent preoperative scintimammography with technetium-99m (Tc-99m)-( V) DMSA and/or Tc-99m-MIBI in consecutive sessions 10 and 60 min after administration of 925 - 1110 MBq of each radiotracer. The tumor-to-background ratio was calculated and correlated with the presence of ER, PR, Ki-67, tumor size, tumor grade, p53, and c-erbB-2. ER, PR, p53, and c-erbB-2 were determined immunohistochemically. The analysis included tumor-to-background ratio of ( V) DMSA and MIBI uptake as dependent and all of the other parameters as independent variables. Results Correlation was positive between Ki-67 and (V) DMSA (r= 0.37 at 10 min, P= 0.038; r= 0.42 at 60 min, P= 0.018) and inverse between PR and (V) DMSA uptake ( r= - 0.46 at 10 min, P= 0.010; r= - 0.51 at 60 min, P= 0.003). Multivariate regression analysis demonstrated a positive correlation between Ki-67 and ( V) DMSA at 60 min ( P= 0.045). Ki-67 was not significantly correlated with MIBI uptake, whereas tumor size was positively correlated with MIBI uptake at 60 min both in univariate ( r= 0.45, P= 0.027) and multivariate analysis ( P= 0.024). Negative correlations were observed between ( V) DMSA uptake and ER, as well as between ER/PR and MIBI uptake, but these were not significant. Conclusion Ki-67 appears to represent the major independent factor affecting (V) DMSA uptake in breast cancer. Tumor size was the only independent parameter influencing MIBI uptake in breast cancer. (V) DMSA appears to have an advantage over MIBI in that it can be used to visualize tumors with intense proliferative activity, and thus it can identify those tumors that are more aggressive.
引用
收藏
页码:R56 / R62
页数:7
相关论文
共 33 条
  • [1] BLOWER PJ, 1991, J NUCL MED, V32, P845
  • [2] FDG uptake in breast cancer:: correlation with biological and clinical prognostic parameters
    Buck, A
    Schirrmeister, H
    Kühn, T
    Shen, CX
    Kalker, T
    Kotzerke, J
    Dankerl, A
    Glatting, G
    Reske, S
    Mattfeldt, T
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (10) : 1317 - 1323
  • [3] Cutrone JA, 1998, J NUCL MED, V39, P449
  • [4] Cwikla JB, 1999, ANTICANCER RES, V19, P2299
  • [5] WHATS NEW IN BREAST-CANCER - MOLECULAR PERSPECTIVES OF CANCER DEVELOPMENT AND THE ROLE OF THE ONCOGENE C-ERBB-2 IN PROGNOSIS AND DISEASE
    DAWKINS, HJS
    ROBBINS, PD
    SMITH, KL
    SAMA, M
    HARVEY, JM
    STERRETT, GF
    PAPADIMITRIOU, JM
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (10) : 1233 - 1252
  • [6] THE NEU-PROTEIN AND BREAST-CANCER
    DEPOTTER, CR
    SCHELFHOUT, AM
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 426 (02): : 107 - 115
  • [7] Hirano T, 1997, J NUCL MED, V38, P1741
  • [8] Hirano T, 1997, J NUCL MED, V38, P20
  • [9] HIRANO T, 1995, J NUCL MED, V36, P202
  • [10] Tc(V)-DMS tumor localization mechanism: A pH-sensitive Tc(V)-DMS - Enhanced target/nontarget ratio by glucose-mediated acidosis
    Horiuchi, K
    Saji, H
    Yokoyama, A
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (06) : 549 - 555